Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
about
Second malignant neoplasms and cardiovascular disease following radiotherapy.Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphomaMilestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current DevelopmentsNational Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent NeoplasmsReappraising the timing of transplant for indolent non-Hodgkin lymphomas.Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphomaIsolated clonal cytogenetic abnormalities after high-dose therapy.Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.Stem cell transplantation in follicular lymphoma: progress at last?High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyLate mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis.Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytesTherapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature.Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions.Stem cell transplantation in Hodgkin lymphoma.Quantitative trait loci associated with susceptibility to therapy-related acute murine promyelocytic leukemia in hCG-PML/RARA transgenic miceSecondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in ChildhoodTherapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.Secondary Myelodysplastic Syndrome May Happen Same as Paraneoplastic Syndrome in a Period of Time and Prior to The Appearance of Malignancy: A case Study of 6 Patients.Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas - a single centre experience.Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma.Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature.High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma.Myelodysplastic syndromes: from neglect to prominence.Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long term disease control. An analysis from the Lymphoma Working Party Of the EBMT.AML transformation after autologous stem cell transplant for multiple myeloma.Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia.
P2860
Q26864522-AFADA761-8EC5-4770-8E31-5C6321ED9A4BQ26999011-B8A88E7D-A304-4D4D-B5FE-A2BD63737C54Q28067102-E1BD5491-753F-4930-8655-436E3F022712Q29248394-3CE6B74A-6475-4CA3-A2C3-B6EC8ECCD3D2Q30248407-01BB9DE4-B11F-4917-9586-8499E0EEA68BQ33706393-C768439A-F83C-4948-A19C-F6314FF19099Q33824082-BAC1338C-39E2-4F8B-9A4F-5D8067949432Q34108964-D8F1D744-BDAD-4BBF-85BE-E2D244302BACQ35023409-0A988F93-6B5D-408B-978A-01227F7F2121Q35613049-8F383580-E03E-47F4-A467-F3EE1A2505ACQ35757247-C6CA7291-A0DF-4BE3-8E8D-520FEDA36B61Q35847602-15E62C93-F32A-4AD0-AF34-6E4A47735572Q35920882-82EA6B31-7555-4074-9963-35901FAF78D1Q35925071-4964DE22-512D-4F4B-B447-A543AA904A53Q36141716-2E2BC0A1-C7CC-4F9C-BB91-10BE16493A1DQ36155132-065B38D2-8E8D-4553-9D44-5A574A64356CQ36194631-64C7F300-38D8-4553-833E-C5EEE93C1300Q36226307-A817038C-2702-4462-BCCA-200F13609D3EQ36282672-F12AE408-DB5C-42C0-889A-C11A3D863125Q36335336-1DC8885B-F9F0-4384-B3D0-BE527898FDAEQ36672691-0FA6B124-7504-4CC1-A2A4-8D285A984A41Q36750533-A049A3D7-54D9-4E99-9ABB-B4D9C176428EQ36752029-4A4160DB-7898-499C-ABB2-6EBDEB03BE9AQ36835079-FA87C21D-4E7C-497E-BF6C-3F6B2FE52D13Q37055896-1D9FCA12-AB9D-4EAA-9F0A-88305A6E53F9Q37548821-1CAF00A7-D17D-469D-84BF-F32F21D2D173Q37552686-C1CE1070-309F-4FDE-B1A9-36BAAC09EF34Q37671462-8C00F3D7-D90C-4266-87B2-AD6BFFC035C8Q37816470-710472A7-7A79-4B11-824D-61B2386FDE59Q37996560-F00E0D7A-486B-41F1-BABB-78E916D142ECQ38045706-5E8460AC-BFDD-4C02-9889-D0EB14AE7187Q38179500-6A5CA5BA-6B3E-449B-8EC1-8B67EE942E6EQ38221521-B4AA6CA8-B84B-4573-A4B1-98195899C10AQ38552083-B1047623-C6D3-47C0-902B-509D2CACFD76Q38798042-2C8FB286-C1EE-450F-A4B1-6EE002F8575CQ39129413-9D5C8000-AAB1-400D-B2FF-021EA205945FQ39422395-5B7B45AD-0D44-4B2B-9FCB-13B27A6DCD32Q39933774-96549030-F768-4707-AF2B-8AA5BEE3A462Q40153767-58E5B95B-A1EF-4C2F-AD32-D1FC9461CFAEQ40328857-0AECE5A8-3E04-4B8E-98F1-1570BF2C2F4F
P2860
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@ast
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@en
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@nl
type
label
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@ast
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@en
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@nl
prefLabel
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@ast
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@en
Myelodysplastic syndrome and a ...... ulticenter case-control study.
@nl
P2093
P921
P1433
P1476
Myelodysplastic syndrome and a ...... multicenter case-control study
@en
P2093
Andrew L Pecora
Carol B Miller
Catherine Metayer
Cesar O Freytes
Chin-Yang Li
Daniel J Weisdorf
J Douglas Rizzo
Joseph W Fay
Kathleen A Sobocinski
Lois B Travis
P304
P356
10.1182/BLOOD-2002-04-1261
P407
P577
2002-10-10T00:00:00Z